Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain ; volume:13 ; number:6 ; day:11 ; month:5 ; year:2024 ; pages:1315-1331 ; date:6.2024
Infectious diseases and therapy ; 13, Heft 6 (11.5.2024), 1315-1331, 6.2024
- Urheber
-
Álvarez Aldean, Javier
Rivero Calle, Irene
Rodríguez Fernández, Rosa
Aceituno Mata, Susana
Bellmunt, Alba
Prades, Miriam
Law, Amy W.
López-Ibáñez de Aldecoa, Alejandra
Méndez, Cristina
García Somoza, María L.
Soto, Javier
Lozano, Virginia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-024-00975-6
- URN
-
urn:nbn:de:101:1-2408060854267.211854674809
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Álvarez Aldean, Javier
- Rivero Calle, Irene
- Rodríguez Fernández, Rosa
- Aceituno Mata, Susana
- Bellmunt, Alba
- Prades, Miriam
- Law, Amy W.
- López-Ibáñez de Aldecoa, Alejandra
- Méndez, Cristina
- García Somoza, María L.
- Soto, Javier
- Lozano, Virginia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants